Literature DB >> 21880840

Replication-incompetent influenza A viruses that stably express a foreign gene.

Makoto Ozawa1,2, Sylvia T Victor3, Andrew S Taft1, Shinya Yamada3, Chengjun Li1, Masato Hatta1, Subash C Das1, Emi Takashita4, Satoshi Kakugawa3, Eileen A Maher1, Gabriele Neumann1, Yoshihiro Kawaoka1,3,5,2.   

Abstract

A biologically contained influenza A virus that stably expresses a foreign gene can be effectively traced, used to generate a novel multivalent vaccine and have its replication easily assessed, all while satisfying safety concerns regarding pathogenicity or reversion. This study generated a PB2-knockout (PB2-KO) influenza virus that harboured the GFP reporter gene in the coding region of its PB2 viral RNA (vRNA). Replication of the PB2-KO virus was restricted to a cell line stably expressing the PB2 protein. The GFP gene-encoding PB2 vRNA was stably incorporated into progeny viruses during replication in PB2-expressing cells. The GFP gene was expressed in virus-infected cells with no evidence of recombination between the recombinant PB2 vRNA and the PB2 protein mRNA. Furthermore, other reporter genes and the haemagglutinin and neuraminidase genes of different virus strains were accommodated by the PB2-KO virus. Finally, the PB2-KO virus was used to establish an improved assay to screen neutralizing antibodies against influenza viruses by using reporter gene expression as an indicator of virus infection rather than by observing cytopathic effect. These results indicate that the PB2-KO virus has the potential to be a valuable tool for basic and applied influenza virus research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880840      PMCID: PMC3352570          DOI: 10.1099/vir.0.037648-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  21 in total

1.  Mapping of functional domains on the influenza A virus RNA polymerase PB2 molecule using monoclonal antibodies.

Authors:  M Hatta; Y Asano; K Masunaga; T Ito; K Okazaki; T Toyoda; Y Kawaoka; A Ishihama; H Kida
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

Review 2.  Perspectives on antiviral use during pandemic influenza.

Authors:  F G Hayden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

3.  Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus.

Authors:  Balaji Manicassamy; Santhakumar Manicassamy; Alan Belicha-Villanueva; Giuseppe Pisanelli; Bali Pulendran; Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

4.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

5.  Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination.

Authors:  Wing-Pui Kong; Chantelle Hood; Zhi-Yong Yang; Chih-Jen Wei; Ling Xu; Adolfo García-Sastre; Terrence M Tumpey; Gary J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

6.  Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies.

Authors:  Luis Martínez-Sobrido; Richard Cadagan; John Steel; Christopher F Basler; Peter Palese; Thomas M Moran; Adolfo García-Sastre
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

7.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

8.  Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity.

Authors:  Baibaswata Nayak; Sachin Kumar; Joshua M DiNapoli; Anandan Paldurai; Daniel R Perez; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

9.  Biological and structural characterization of a host-adapting amino acid in influenza virus.

Authors:  Shinya Yamada; Masato Hatta; Bart L Staker; Shinji Watanabe; Masaki Imai; Kyoko Shinya; Yuko Sakai-Tagawa; Mutsumi Ito; Makoto Ozawa; Tokiko Watanabe; Saori Sakabe; Chengjun Li; Jin Hyun Kim; Peter J Myler; Isabelle Phan; Amy Raymond; Eric Smith; Robin Stacy; Chairul A Nidom; Simon M Lank; Roger W Wiseman; Benjamin N Bimber; David H O'Connor; Gabriele Neumann; Lance J Stewart; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

10.  Influenza virus assays based on virus-inducible reporter cell lines.

Authors:  Yunsheng Li; Audrey Larrimer; Teresa Curtiss; Jaekyung Kim; Abby Jones; Heather Baird-Tomlinson; Andrew Pekosz; Paul D Olivo
Journal:  Influenza Other Respir Viruses       Date:  2009-09       Impact factor: 4.380

View more
  36 in total

1.  A replication-incompetent PB2-knockout influenza A virus vaccine vector.

Authors:  Sylvia T Victor; Shinji Watanabe; Hiroaki Katsura; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread.

Authors:  Vy Tran; Lindsey A Moser; Daniel S Poole; Andrew Mehle
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

3.  A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges.

Authors:  Ryuta Uraki; Maki Kiso; Kiyoko Iwatsuki-Horimoto; Satoshi Fukuyama; Emi Takashita; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

4.  Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).

Authors:  Steven F Baker; Aitor Nogales; Felix W Santiago; David J Topham; Luis Martínez-Sobrido
Journal:  Vaccine       Date:  2015-06-01       Impact factor: 3.641

5.  Development of Stable Rotavirus Reporter Expression Systems.

Authors:  Yuta Kanai; Takahiro Kawagishi; Ryotaro Nouda; Misa Onishi; Pimfhun Pannacha; Jeffery A Nurdin; Keiichiro Nomura; Yoshiharu Matsuura; Takeshi Kobayashi
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

6.  Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.

Authors:  Alexandra H Dudek; Florian Pfaff; Hardin Bolte; Collins Waguia Kontchou; Martin Schwemmle
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

7.  Influenza A viruses with different amino acid residues at PB2-627 display distinct replication properties in vitro and in vivo: revealing the sequence plasticity of PB2-627 position.

Authors:  Alex W H Chin; Olive T W Li; Chris K P Mok; Miko K W Ng; Malik Peiris; Leo L M Poon
Journal:  Virology       Date:  2014-09-28       Impact factor: 3.616

8.  Competitive incorporation of homologous gene segments of influenza A virus into virions.

Authors:  Arisa Inagaki; Hideo Goto; Satoshi Kakugawa; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

9.  A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.

Authors:  Wendy Fonseca; Makoto Ozawa; Masato Hatta; Esther Orozco; Máximo B Martínez; Yoshihiro Kawaoka
Journal:  Arch Virol       Date:  2013-12-01       Impact factor: 2.574

Review 10.  Development and applications of single-cycle infectious influenza A virus (sciIAV).

Authors:  Aitor Nogales; Steven F Baker; William Domm; Luis Martínez-Sobrido
Journal:  Virus Res       Date:  2015-07-26       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.